OR WAIT null SECS
The new device can inject a range of drugs of different viscosities up to 35cP and different fill volumes up to 1mL.
Becton, Dickinson, and Company (BD), a medical technology company based in Switzerland, introduced the BD Intevia, a 1-mL two-step disposable autoinjector that combines an autoinjector and pre-fillable syringe into one platform device.
According to an Oct. 21, 2019 press release, the new device can inject a range of drugs of different viscosities up to 35cP and different fill volumes up to 1 mL. It comes equipped with a two-step, push-on-skin activation option for patient control and feedback indicators that alert the patients when the dose has been delivered and triggers an audible click. The design also allows the pharmaceutical industry to use the device without customizing its system components.
“BD Intevia is a new generation of BD autoinjectors that will help drug manufacturers seamlessly enhance drug delivery experience,” said Peter Nolan, worldwide president, BD Medical-Pharmaceutical Systems, in the press release. “For the patient, the platform technology is designed to promote patient ease of use when self-injecting, and it is supported by BD’s worldwide clinical injection expertise harnessing the latest research in drug delivery technology.”
BD will showcase its products at Stand 111C70 at CPhI Worldwide from Nov. 5–7 in Frankfurt, Germany.